Episode description
When corporations install anti-activist poison pills they are less likely to implement new share buybacks and their operationally-focused capital expenditures tend to be higher, UC Berkeley School of Law professor Ofer Eldar explains.
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast